Media Gallery

ZIM Laboratories Limited: A Vision in Innovation

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Silicon India covers Zim Laboratories

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

View

Video Gallery

Zim Laboratories Limited Corporate Film
Zim Laboratories Limited - Oral Thin Film

Zim Gallery

Thumbnail Slider Image
Thumbnail Slider Image
Thumbnail Slider Image
Thumbnail Slider Image
Thumbnail Slider Image

Press Releases

View All
2022
View

ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS.

2021

Zim Laboratories Limited has been granted marketing rights for Rizatriptan by Infarmed, for its European subsidiaries.

View
2020

ZIM Laboratories Limited and Hypera Pharma Group enter into an exclusive licensing agreement of Vitamin D3 Orally Disintegrating Strips.

View
2019

ZIM Laboratories Limited and Neuraxpharm enter into an exclusive co-development agreement

View

ZIM Laboratories At CPHI: 2022

View

CPHI Corporate Presentation

Stall Posters

View

Product Lists

Nutraceuticals ProductsOral Thin Films ProductsRegulated Markets Products Pre Formulation Intermediates ProductsCephalosporin Products
PRODUCTS
INVESTORS
TECHNOLOGY
CAREERS
CONTACT
CONNECT WITH US

© Copyright 2024, ZIM LABORATORIES LIMITED | CIN-L99999MH1984PLC032172
Disclaimer | Cookie Policy | QR Scan